{
    "clinical_study": {
        "@rank": "159970", 
        "brief_summary": {
            "textblock": "This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment\n      and follow-up for NCI patients not currently entered on an active research protocol.  No\n      investigational treatments will be administered on this protocol."
        }, 
        "brief_title": "Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease", 
        "condition": [
            "Acquired Immunodeficiency Syndrome", 
            "Neoplasm", 
            "Skin Disease", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Neoplasms", 
                "Immunologic Deficiency Syndromes", 
                "Skin Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Background:\n\n      It may be in the interest of the CCR to continue to follow and treat certain subjects after\n      they have completed their treatment and participation on a research protocol.\n\n      Objective:\n\n      To provide continuing treatment and medical follow-up for CCR subjects who have completed\n      their treatment and participation on a research protocol and who are not currently entered\n      on or eligible for another active research protocol.\n\n      Eligibility:\n\n      Subjects who have been previously enrolled on and received treatment according to an\n      approved CCR research protocol. (clinical trial)\n\n      It is in the best interest of the subject and the CCR for the subject to continue to receive\n      standard care and follow-up at the NIH.\n\n      Design:\n\n      Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects\n      who have completed their treatment and participation on a research protocol and who are not\n      currently entered on an active research protocol.\n\n      No investigational treatments will be administered. This protocol is not be used as a\n      platform to perform pilot studies of off-label uses for standard agents."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Subjects of any age who have been previously enrolled and treated on an approved CCR\n        research treatment protocol.\n\n        It is in the best interests of the subject and the CCR for the subject to continue to\n        receive treatment and follow-up at the NIH.\n\n        The subject or guardian signs the informed consent and agrees to the proposed treatment\n        regimen.\n\n        EXCLUSION CRITERIA:\n\n        Subjects who have not been previously treated on a CCR research treatment protocol.\n\n        Subjects who are receiving an investigational therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "2143", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001295", 
            "org_study_id": "920094", 
            "secondary_id": "92-C-0094"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Standard Care", 
            "Follow-Up", 
            "Bridge Protocol"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_1992-C-0094.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Continuing Treatment for Children and Adults in the Center for Cancer Research", 
        "overall_official": {
            "affiliation": "National Cancer Institute (NCI)", 
            "last_name": "Caryn Steakley, R.N.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001295"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1992", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}